Evidence & Value

Healthcare costs are climbing, regulators around the globe are requiring more information, and both providers and payers have higher expectations for a medical treatment’s proof of value before prescribing or paying for those treatments.

Featured Video

Quintiles Blog

Fresh ideas and insights from our experts around the globe


Quintiles Authors

Senior Vice President, Real-World Insights

Senior Vice President, Advisory Services

Peer-Reviewed Publications

Did you know...

“Efficacy” is the top definition of value for US payers.
US providers most often define value as “improved quality of life.”
“Addressing unmet medical need” is biopharma’s top definition of value.